Prosecution Insights
Last updated: September 25, 2026
Application No. 18/025,468

NEBULIZER AND NEBULIZER SYSTEM

Non-Final OA §102§112
Filed
Mar 09, 2023
Priority
Sep 09, 2020 — EU 20195298.3 +1 more
Examiner
SIPPEL, RACHEL T
Art Unit
3785
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Pulmotree Medical GmbH
OA Round
3 (Non-Final)
52%
Grant Probability
Moderate
3-4
OA Rounds
3m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 52% of resolved cases
52%
Career Allowance Rate
423 granted / 809 resolved
-17.7% vs TC avg
Strong +58% interview lift
Without
With
+58.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
41 currently pending
Career history
846
Total Applications
across all art units

Statute-Specific Performance

§101
4.2%
-35.8% vs TC avg
§103
49.3%
+9.3% vs TC avg
§102
15.3%
-24.7% vs TC avg
§112
26.3%
-13.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 809 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Amendment This office action is responsive to the amendment filed on 7/6/26. As directed by the amendment: claims 1, 5 and 9-10 have been amended, claims 7 and 13-22 have been canceled, and no new claims have been added. Thus, claims 1-6 and 8-12 are presently pending in the application. Claims 11-12 are withdrawn as being directed towards a non-elected group and species. Allowable Subject Matter Claims 5-6 and 9-10 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Claim Interpretation The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are: “retaining elements” in claim 9 (corresponding structure is gripping hooks, Page 10, lines 12-13). “ejection means” in claim 10 (corresponding structure is spring-loaded ejection plunger, Page 10, lines 16-18). Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof. If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 8-10 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 8 recites “according to claim 1 any preceding claim” however it is unclear as to which claim applicant is referring back to. As best understood claim 8 is dependent on claim 1, which is how the claim will be interpreted for examination purposes. Any remaining claims are rejected as being dependent on a rejected base claim. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-4 and 8 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Harrison (2005/0028813). Regarding claim 1, in fig. 1-3a Harrison discloses mesh nebulizer ([0023] mesh insert for atomization) comprising a dosing unit (11, 5b, 5a and 3) for providing a predetermined amount of a therapeutic agent (within medicament container 3), and a nebulizer head (portion surrounding nozzle 15 that contains the mesh insert [0023]), the nebulizer head comprises an aerosol generator ([0023] mesh insert atomizes the liquid) for generating an aerosol made from said therapeutic agent [0023], wherein said therapeutic agent is delivered in a portion container 3 to be opened by pressure [0033-0034]; wherein the dosing unit comprises an uptake chamber (where 3 resides) with a dosing opening (see opening of 3 in fig. 2 caused by the opening of frangible portion 17) for dispensing the therapeutic agent into the aerosol generator, an opening (where arrow is pointing in fig. 3a) for inserting the portion container 3 and a locking body 23 for locking the opening for inserting the portion container 3 [0035], wherein the dosing unit further comprises said portion container 3, the portion container having a top cover (top portion of 3) and a bottom cover (bottom portion of 3), which are connected along a sealing seam (3 has heat sealed flat-edges, which therefore form a sealing seam [0033]), a volume is formed between the top cover and the bottom cover (see fig. 1), which is filled with the therapeutic agent [0033]; wherein the locking body is adapted to be moved from an open position in which the locking body releases the opening for inserting the portion container (see fig. 3a) to a closed position (Fig. 1) in which the locking body closes the opening for inserting the portion container (Fig. 1); and wherein the locking body is further adapted to be moved from the closed position (Fig. 1) to a drainage position (Fig. 2) in which the locking body applies pressure to the portion container in a non-piercing way [0033-0034] to open the portion container and release the therapeutic agent into the aerosol generator [0033-0034], in which the aerosol is then generated upon demand ([0033-0034]). Regarding claim 2, Harrison discloses that the movement of the locking body from the open position to the closed position is or comprises a linear movement (the linear movement occurs during locking as upper facing surface 21a is linear and slides along linear surface 23). Regarding claim 3, Harrison discloses that the movement of the locking body from the open position to the closed position is or comprises a rotating movement (Fig. 1-3a shows pivoting rotation from an open to a closed position). Regarding claim 4, Harrison discloses that the movement of the locking body from the closed position to the drainage position is or comprises a rotating movement (Fig.1-2 shows further pivoting rotation from a closed position to the final drainage position). Regarding claim 8, Harrison discloses that the dosing unit comprises a removal handle (5b is a handle since the user can grip it with their hand to later removed used portion container 3) for discharged portion containers. Response to Arguments Applicant’s arguments, see pages 4-5, filed 7/6/26, with respect to the rejections of claim 1 under U.S.C. 103 in view of Pieters, Gallem, Leonard and Harrison as well as Pieters, Gallem, Leonard and Boyes have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new ground of rejection is made in view of Harrison. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to RACHEL T SIPPEL whose telephone number is (571)270-1481. The examiner can normally be reached M-F 9:00-5:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Timothy Stanis can be reached at (571) 272-5139. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /RACHEL T SIPPEL/Primary Examiner, Art Unit 3785
Read full office action

Prosecution Timeline

Show 7 earlier events
Jul 06, 2026
Request for Continued Examination
Jul 14, 2026
Response after Non-Final Action
Jul 21, 2026
Examiner Interview (Telephonic)
Jul 23, 2026
Non-Final Rejection mailed — §102, §112
Sep 08, 2026
Interview Requested
Sep 14, 2026
Examiner Interview Summary
Sep 14, 2026
Applicant Interview (Telephonic)
Sep 15, 2026
Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12721773
INTERMETATARSAL SPACE VIBRATOR
3y 3m to grant Granted Sep 01, 2026
Patent 12721960
DEVICE FOR NASAL DELIVERY OF A FLUID PRODUCT
2y 8m to grant Granted Sep 01, 2026
Patent 12708728
TRACHEAL TUBE ASSEMBLY
3y 5m to grant Granted Aug 18, 2026
Patent 12702778
TRACHEOSTOMA DEVICE HOLDER
3y 8m to grant Granted Aug 11, 2026
Patent 12691235
CARTRIDGE UNIT COUPLER
5y 3m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
52%
Grant Probability
99%
With Interview (+58.3%)
3y 10m (~3m remaining)
Median Time to Grant
High
PTA Risk
Based on 809 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month